Tumour growth in LUCAT1-enriched exosomes treatment group was faster than that of control groups, and chemoresistance in LUCAT1-enriched exosomes treatment group was enhanced compared with control groups (Fig. 7F). The gene discussed is LUCAT1; the disease is neoplasm.